Could a quick bedside biopsy replace the standard for diabetic foot infections?
NCT ID NCT06066801
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a bedside bone biopsy, done in the patient's room, works as well as the usual surgical or radiology-guided biopsy to diagnose bone infection in diabetic foot ulcers. The trial will include 320 adults with diabetes and signs of foot bone infection. If the bedside method proves non-inferior, it could offer a simpler, faster way to guide antibiotic treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bedside blind bone biopsy procedure
- What this could lead to
- If successful, this could make diagnosing bone infections in diabetic foot ulcers simpler and more accessible, potentially reducing delays in treatment.
- What could go wrong
- This is a non-inferiority trial testing a procedure already used in practice, so it may not show a major improvement. The bedside method might be less accurate than the standard approach.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT OSTEOMYELITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bichat - Claude Bernard Hospital
RECRUITINGParis, 75018, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.